Health Discovery
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2013 | -1.76M | 1.51M | 150.78K |
|---|---|---|---|
| 2014 | -736.16K | 499.82K | 172K |
| 2015 | -608.60K | 330.17K | 688K |
| 2016 | -465.95K | 0 | 90K |
| 2017 | -314.00K | 141.29K | 175K |
| 2018 | -275.53K | 0 | 232.06K |
| 2019 | 2.20M | 0 | 92.94K |
| 2020 | -1.37M | 0 | 0 |
| 2021 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 |
HDVY Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 917K | 2.29M | 67 | 43.54K | 41.25K | 417.20K | 7.64K | 71.99K | 171.42K |
Operating activities | ||||||||||
Net income | 0 | 0 | -759K | 1.56M | -795.47K | -873.88K | -2.06M | -587.06K | 176.64K | -774.92K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 152.90K | 262.71K | 262.71K | 262.91K | 263.64K | 267.35K | 270.63K |
Stock-based compensation expense | 0 | 0 | 268K | 513K | 0 | 65.93K | 196.72K | 68.28K | 73.76K | 30.85K |
| Deferred income tax benefit | 0 | 0 | 268K | 513K | 0 | 65.93K | 196.72K | 68.28K | 73.76K | 30.85K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | -126.72K | -4.44K | 112.82K | 71.93K | 1.96K | -1.88K | 10 |
Inventories | 0 | 0 | 0 | 247.67K | 222.47K | 35.88K | -71.93K | 0 | -2.5K | -53K |
Accounts payable | 0 | 0 | 107K | -126.72K | -4.44K | 112.82K | 71.93K | -80.77K | -86.35K | 186.47K |
Cash generated by operating activities | 0 | 0 | -1.37M | 2.20M | -275.53K | -314.00K | -465.95K | -608.60K | -736.16K | -1.76M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.29K | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.33K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 0 | 141.29K | 0 | 330.17K | 499.82K | 1.51M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 90K | 120K | 172K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.21K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 93K | -232.06K | 175K | 0 | 0 | 0 | 0 |
Cash used in financing activities | 0 | 0 | 0 | 92.94K | 232.06K | 175K | 90K | 688K | 172K | 150.78K |
Net Change In Cash | 0 | 0 | -1.37M | 2.29M | -43.47K | 2.29K | -375.95K | 409.56K | -64.34K | -99.43K |
Cash at end of period | 0 | 917K | 917K | 2.29M | 67 | 43.54K | 41.25K | 417.20K | 7.64K | 71.99K |
| Data source | Data source | Data source | Data source | Data source |